Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP.
Tomono Kawase
No relevant relationships to disclose
Hiroshi Imamura
Honoraria - Taiho Pharmaceutical
Masahiro Gotoh
No relevant relationships to disclose
Yutaka Kimura
Honoraria - Taiho Pharmaceutical
Shugo Ueda
No relevant relationships to disclose
Jin Matsuyama
No relevant relationships to disclose
Kazuhiro Nishikawa
No relevant relationships to disclose
Naotoshi Sugimoto
Honoraria - Taiho Pharmaceutical; Yakult Honsha
Research Funding - Taiho Pharmaceutical; Yakult Honsha
Junya Fujita
No relevant relationships to disclose
Takao Tamura
No relevant relationships to disclose
Norimasa Fukushima
No relevant relationships to disclose
Ryohei Kawabata
Honoraria - Taiho Pharmaceutical
Yukinori Kurokawa
Honoraria - Taiho Pharmaceutical
Toshio Shimokawa
No relevant relationships to disclose
Daisuke Sakai
No relevant relationships to disclose
Toshimasa Tsujinaka
No relevant relationships to disclose
Hiroshi Furukawa
No relevant relationships to disclose